Internship

Intern – Patient Safety

Oncology

Confirmed live in the last 24 hours

Gilead Sciences

Gilead Sciences

10,001+ employees

Develops and commercializes biopharmaceuticals for various diseases

Biotechnology
Healthcare

Compensation Overview

$19 - $55Hourly

No H1B Sponsorship

San Mateo, CA, USA

Must be authorized to work in the United States without sponsorship and must be able to relocate if necessary.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Risk Management

You match the following Gilead Sciences's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Must be at least 18 years old
  • Must have a minimum GPA of 2.8
  • Authorized to work in the United States without Sponsorship now or in the future or CPT/OPT through your University.
  • Must be currently enrolled as a full-time student in a Bachelor’s/Masters/MBA/PhD program at an accredited US based university or college
  • Must be a Rising Sophomore, Junior, or Senior in undergrad or a Graduate or Doctoral Student
  • Must be enrolled full-time in the Fall Semester at an accredited university/college after the completion of the internship
  • Must be able to complete a 10-12 consecutive week internship between May and August
  • Must be able to relocate if necessary and work at the designated site for the duration of the internship
Responsibilities
  • Supports authoring or otherwise contributes to the preparation of aggregate safety reports and risk management plans (RMPs).
  • Conducts signal detection and evaluation activities for assigned products in collaboration with the Global TA Safety Physician and Scientist as part of the continuous benefit-risk evaluation throughout the product lifecycle.
  • Supports implementation of decisions from the signal evaluation process, including updates to core safety information, Investigator’s Brochure and other key safety documents and deliverables.
  • May contribute to MSS activities and input related to regulatory filings, New Drug Applications [NDAs], Biologics License Applications [BLAs]), and responses to safety queries from third parties, such as regulatory agencies.
  • May perform safety reviews of clinical trial protocols, Investigator’s Brochures, clinical study reports, informed consent forms, and other study related documents.
  • Ensures own work complies with established practices, policies and processes, and any regulatory or other requirements.
  • Showcase your work with a final poster board presentation near the conclusion of your internship
  • Showcase your work with a final presentation (PPT) near the conclusion of your internship
Desired Qualifications
  • Preferred Degree qualification: Graduate/PharmD
  • Proficiency with MS Office Suite
  • Ability to identify issues and seek solutions
  • Ability to work both independently and collaboratively
  • Demonstrated commitment to inclusion and diversity in the workplace
  • Efficient, organized, and able to handle short timelines in a fast-paced environment

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Company Stage

IPO

Total Funding

$15.9B

Headquarters

Foster City, California

Founded

1987

Simplify Jobs

Simplify's Take

What believers are saying

  • Partnership with LEO Pharma strengthens Gilead's inflammation research portfolio.
  • Lenacapavir positions Gilead as a leader in HIV care innovation.
  • Collaboration with Tubulis expands Gilead's oncology treatment options.

What critics are saying

  • Increased competition in HIV market from ViiV Healthcare's expanding portfolio.
  • Regulatory scrutiny may challenge lenacapavir's commercialization.
  • STAT6 program may not meet clinical expectations, impacting inflammation research.

What makes Gilead Sciences unique

  • Gilead's lenacapavir is a breakthrough in innovative HIV treatments.
  • Strategic partnerships enhance Gilead's inflammation and oncology research portfolios.
  • Gilead's robust R&D pipeline focuses on unmet medical needs globally.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options